Impact of National Omicron Outbreak at the end of 2022 on the future outlook of COVID-19 in China
Top Cited Papers
Open Access
- 27 March 2023
- journal article
- editorial
- Published by Taylor & Francis Ltd in Emerging Microbes & Infections
- Vol. 12 (1), 2191738
- https://doi.org/10.1080/22221751.2023.2191738
Abstract
The sudden change of public health policy in containing COVID-19 in China around December 7, 2022 and the subsequent immediate large scale outbreak of severe acute respiratory syndrome coronavirus ...Keywords
Funding Information
- National Natural Science Foundation of China (8214100646)
This publication has 20 references indexed in Scilit:
- Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2Cell Host & Microbe, 2023
- Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort studyThe Lancet Microbe, 2022
- Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational studyThe Lancet Infectious Diseases, 2022
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) VariantThe New England Journal of Medicine, 2022
- Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variantNature, 2022
- The T cell immune response against SARS-CoV-2Nature Immunology, 2022
- Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccinesJournal of Medical Virology, 2022
- Omicron variant genome evolution and phylogeneticsJournal of Medical Virology, 2021
- Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidatesEmerging Microbes & Infections, 2021
- An interactive web-based dashboard to track COVID-19 in real timeThe Lancet Infectious Diseases, 2020